Physician profile
Mandy L Rust
NPI 1881186781
$4,711.01
in general payments reported to CMS, 2019-2025
22 companies · $645 in 2025
The $645 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $983 · 2022: $1,049 · 2023: $1,546 · 2024: $488 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,864 · Travel and Lodging: $769 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,864.30 |
| Travel and Lodging | $769.28 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,325.47 | 2021-2024 | Linq II, Reveal Linq, Percepta Quad Crt-P Mri Surescan |
| Amgen INC. | $384.48 | 2021-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $327.15 | 2021-2025 | Farxiga, Lokelma |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $279.38 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $276.05 | 2021-2024 | |
| Abbott Laboratories | $163.11 | 2021-2024 | Tacticath Ablation Catheter, Sensor Enabled, Na, Viewmate |
| Pfizer INC. | $147.30 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.60 | 2021-2024 | Jardiance |
| Biotronik INC. | $93.39 | 2022-2023 | Rivacor 7 Dr-T, Acticor 7 Vr-T Dx, Plexa Promri |
| Kestra Medical Technology Services, INC. | $82.96 | 2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $81.20 | 2021 | |
| Merck Sharp & Dohme LLC | $64.85 | 2021-2022 | |
| Novo Nordisk INC | $64.33 | 2021-2025 | Wegovy |
| Amarin Pharma, INC. | $50.48 | 2021 | |
| Janssen Pharmaceuticals, INC | $48.75 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $47.51 | 2021 | |
| Impulse Dynamics (USA) INC. | $38.32 | 2024 | Optimizer |
| Boston Scientific Corporation | $24.42 | 2022 | |
| Inspire Medical Systems, INC. | $21.68 | 2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $19.02 | 2025 | Amvuttra |
| Bayer Healthcare Pharmaceuticals INC. | $16.97 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandy Rust listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.